Matthew J. Ehrhardt

5.1k total citations · 1 hit paper
119 papers, 1.7k citations indexed

About

Matthew J. Ehrhardt is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matthew J. Ehrhardt has authored 119 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pediatrics, Perinatology and Child Health, 55 papers in Public Health, Environmental and Occupational Health and 25 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matthew J. Ehrhardt's work include Childhood Cancer Survivors' Quality of Life (100 papers), Acute Lymphoblastic Leukemia research (48 papers) and Chemotherapy-induced cardiotoxicity and mitigation (24 papers). Matthew J. Ehrhardt is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (100 papers), Acute Lymphoblastic Leukemia research (48 papers) and Chemotherapy-induced cardiotoxicity and mitigation (24 papers). Matthew J. Ehrhardt collaborates with scholars based in United States, Canada and Sweden. Matthew J. Ehrhardt's co-authors include Melissa M. Hudson, Kirsten K. Ness, Leslie L. Robison, Daniel A. Mulrooney, Gregory T. Armstrong, Yutaka Yasui, Deo Kumar Srivastava, Nickhill Bhakta, Kevin R. Krull and Qi Liu and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Matthew J. Ehrhardt

105 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort

2023 77 citations Stephanie B. Dixon, Qi Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew J. Ehrhardt United States	21	1.0k	568	500	331	263	119	1.7k
Renée L. Mulder Netherlands	25	1.2k 1.2×	792 1.4×	399 0.8×	481 1.5×	286 1.1×	50	2.1k
A. C. Mertens United States	3	752 0.7×	410 0.7×	706 1.4×	263 0.8×	218 0.8×	5	1.4k
Can-Lan Sun United States	18	732 0.7×	657 1.2×	440 0.9×	773 2.3×	312 1.2×	18	2.2k
Lars Hjorth Sweden	23	870 0.8×	607 1.1×	184 0.4×	438 1.3×	628 2.4×	80	2.2k
Ellen Ruud Norway	31	1.0k 1.0×	721 1.3×	201 0.4×	437 1.3×	324 1.2×	119	2.4k
Kerri Nottage United States	18	1.2k 1.1×	662 1.2×	144 0.3×	553 1.7×	148 0.6×	36	2.2k
Liton Francisco United States	34	1.5k 1.4×	1.2k 2.1×	605 1.2×	1.1k 3.2×	312 1.2×	109	3.9k
Karsten Nysom Denmark	25	797 0.8×	740 1.3×	237 0.5×	425 1.3×	240 0.9×	109	2.0k
H.N. Caron Netherlands	24	678 0.7×	359 0.6×	204 0.4×	406 1.2×	259 1.0×	58	1.8k

Countries citing papers authored by Matthew J. Ehrhardt

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Ehrhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Ehrhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Ehrhardt more than expected).

Fields of papers citing papers by Matthew J. Ehrhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Ehrhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Ehrhardt. The network helps show where Matthew J. Ehrhardt may publish in the future.

Co-authorship network of co-authors of Matthew J. Ehrhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Ehrhardt. A scholar is included among the top collaborators of Matthew J. Ehrhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Ehrhardt. Matthew J. Ehrhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, AnnaLynn M., Nicholas S. Phillips, Qian Dong, et al.. (2025). Epigenetic age acceleration, telomere length, and neurocognitive function in long-term survivors of childhood cancer. Nature Communications. 16(1). 10655–10655.

Mulrooney, Daniel A., Isaac Rhea, Christine Yu, et al.. (2024). Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer. JACC CardioOncology. 6(1). 16–32. 9 indexed citations

Williams, AnnaLynn M., Matthew J. Ehrhardt, Angela Panoskaltsis‐Mortari, et al.. (2024). Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma. Clinical Cancer Research. 30(9). 1822–1832. 2 indexed citations

Dong, Qian, Kyla Shelton, Tara M. Brinkman, et al.. (2024). Characterization of Patient Activation among Childhood Cancer Survivors in the St. Jude Lifetime Cohort Study (SJLIFE). Cancers. 16(18). 3220–3220.

Onerup, Aron, Qi Liu, Shizue Izumi, et al.. (2024). Comparing the impact of insufficient physical activity on cardiovascular disease in survivors of childhood Hodgkin lymphoma and sibling controls: A report from the Childhood Cancer Survivor Study (CCSS).. Journal of Clinical Oncology. 42(16_suppl). 10024–10024.

Wang, Mei, Tuo Lan, AnnaLynn M. Williams, et al.. (2024). Plant Foods Intake and Risk of Premature Aging in Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort (SJLIFE). Journal of Clinical Oncology. 42(13). 1553–1562. 4 indexed citations

Lan, Tuo, Mei Wang, Matthew J. Ehrhardt, et al.. (2024). Dietary patterns and their associations with sociodemographic and lifestyle factors in adult survivors of childhood cancer: a cross-sectional study. American Journal of Clinical Nutrition. 119(3). 639–648. 3 indexed citations

Green, Daniel M., Sue C. Kaste, Kirsten K. Ness, et al.. (2024). Kidney Function and Body Composition in Adult Survivors of Unilateral, Non‐Syndromic Wilms Tumor: A Report From the St. Jude Lifetime Cohort Study. Pediatric Blood & Cancer. 72(3). e31485–e31485.

Ehrhardt, Matthew J., Qi Liu, Daniel A. Mulrooney, et al.. (2024). Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy. Journal of Clinical Oncology. 42(11). 1265–1277. 6 indexed citations

10.

Liu, Qi, Fan Wang, Xiao Peng, et al.. (2024). Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia. Journal of Allergy and Clinical Immunology. 155(2). 640–649. 1 indexed citations

11.

Lan, Tuo, AnnaLynn M. Williams, Matthew J. Ehrhardt, et al.. (2024). Sugar and sugar-sweetened beverages in relation to premature aging in adult survivors of childhood cancer. British Journal of Cancer. 131(7). 1169–1177. 2 indexed citations

12.

Ackermann, Nicole, et al.. (2024). Translating a motivational interviewing intervention for childhood cancer survivors into an eHealth tool: A user-centered design process. Translational Behavioral Medicine. 14(6). 359–367. 1 indexed citations

13.

Williams, AnnaLynn M., Jeanne S. Mandelblatt, Mingjuan Wang, et al.. (2023). Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer. JAMA Network Open. 6(11). e2344015–e2344015. 6 indexed citations

14.

Howell, Carrie R., Tara M. Brinkman, Matthew J. Ehrhardt, et al.. (2023). The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1021–1029. 3 indexed citations

15.

Lan, Tuo, Mei Wang, Matthew J. Ehrhardt, et al.. (2023). Adherence to healthy diet and risk of cardiovascular disease in adult survivors of childhood cancer in the St. Jude Lifetime Cohort: a cross-sectional study. BMC Medicine. 21(1). 242–242. 8 indexed citations

16.

Chen, Yan, Bryan V. Dieffenbach, Matthew J. Ehrhardt, et al.. (2023). Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer. Journal of Clinical Oncology. 41(12). 2258–2268. 7 indexed citations

17.

Wilson, Carmen L., Tara M. Brinkman, Sujuan Huang, et al.. (2020). Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort. Cancer. 126(6). 1330–1338. 12 indexed citations

18.

Sapkota, Yadav, Na Qin, Matthew J. Ehrhardt, et al.. (2020). Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry. Cancer Research. 81(9). 2556–2565. 24 indexed citations

19.

Williams, Hannah, Carrie R. Howell, Wassim Chemaitilly, et al.. (2019). Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study. Cancer. 126(4). 870–878. 19 indexed citations

20.

Wang, Zhaoming, Qi Liu, Carmen L. Wilson, et al.. (2018). Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE). Clinical Cancer Research. 24(24). 6230–6235. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact